Cue Biopharma, Inc.

CUEReported to SECin USCIK 0001645460Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 35. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 35
Form 4 lines at Cue Biopharma, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Sarraf Pasha—Awardnothing paid18,400 sharesAug 28, 2026Sarraf Pashanothing paidAward · Aug 28Award18,400Aug 28, 2026
Garzone Pamela—Awardnothing paid18,900 sharesAug 28, 2026Garzone Pamelanothing paidAward · Aug 28Award18,900Aug 28, 2026
Meluzio Michael VincentVP, Prin. Accounting OfficerOption exercisenothing paid13,647 sharesAug 17, 2026Meluzio Michael VincentVP, Prin. Accounting Officernothing paidExercise · Aug 17Option exercise13,647Aug 17, 2026
Meluzio Michael VincentVP, Prin. Accounting OfficerOpen-market sell$933 sharesAug 17, 2026Meluzio Michael VincentVP, Prin. Accounting Officer$93Sell · Aug 17Open-market sell3Aug 17, 2026
Meluzio Michael VincentVP, Prin. Accounting OfficerOpen-market sell$124,6174,106 sharesAug 17, 2026Meluzio Michael VincentVP, Prin. Accounting Officer$124,617Sell · Aug 17Open-market sell4,106Aug 17, 2026